Cargando…
Immortal Ozurdex: A 10-month follow-up of an intralenticular implant
A 78-year-old male who had received a dexamethasone implant (Ozurdex, Allergan, Inc., Irvine, CA, USA) 15 days back for recalcitrant diabetic macular edema in the left eye came to us for a second opinion. On examination, his corrected distance visual acuity was 20/20 in the right eye and 20/40 in th...
Autores principales: | Poornachandra, B, Kumar, Vinod B M, Jayadev, Chaitra, Dorelli, Subashchandra H, Yadav, Naresh Kumar, Shetty, Rohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426136/ https://www.ncbi.nlm.nih.gov/pubmed/28440260 http://dx.doi.org/10.4103/ijo.IJO_634_16 |
Ejemplares similares
-
The nomadic Ozurdex(®): Anterior migration of the dexamethasone implant and back!
por: Srinivasan, Priya, et al.
Publicado: (2017) -
Inadvertent intralenticular Ozurdex removal
por: Roy, Madhurima, et al.
Publicado: (2022) -
Intralenticular Ozurdex® - One Year Later
por: Regan, Kathleen A., et al.
Publicado: (2017) -
Intralenticular Ozurdex injection in an eye with thicker lens and the therapeutic effect maintained for 15 months
por: Li, Mu, et al.
Publicado: (2022) -
Intralenticular subcapsular air
por: Natesh, Sribhargava, et al.
Publicado: (2010)